BURWIG SUSAN E

Exec. VP, Operations

BURWIG SUSAN E has filed 15 SEC Form 4 filings (17 transaction rows) across 1 company, with disclosures dating back to 2025. 11 of those filings fall inside the rolling window. Most recent filing: Oct 28, 2026.

On the most recent filing, BURWIG SUSAN E is listed as Exec. VP, Operations at Medpace Holdings, Inc. Inside the rolling window, BURWIG SUSAN E reported no open-market purchases and 4 open-market sales totaling $30.2M in MEDP. The largest disclosed transaction in the window is a sale of 20,000 MEDP shares on Nov 24, 2025, worth $12.2M.

Companies traded

Other insiders at MEDP

Insider Buying

$0

reported purchases (SEC code P)

Insider Selling

$30.2M

reported sales (SEC code S)

Companies

1

in the rolling window

Source
MEDPSale$10.9MOct 28SEC ↗
MEDPSale$2.7MOct 28SEC ↗
MEDPSale$4.5MJul 29SEC ↗
MEDPSale$12.2MNov 26SEC ↗
Showing 1–4 of 4
1 / 1

Earlier trades

Open-market purchases and sales filed before the rolling 365-day window, kept from the original Form 4 filings.

DateTickerTypeValue
Nov 11, 2025MEDPSale$10.9M
Oct 27, 2025MEDPSale$1.2M
Sep 3, 2025MEDPSale$4.8M
Showing 1–3 of 3
1 / 1

Frequently asked questions

How many SEC Form 4 filings has BURWIG SUSAN E made?

BURWIG SUSAN E has filed 15 SEC Form 4 filings (17 transaction rows) across 1 company since 2025.

Which companies does BURWIG SUSAN E trade?

BURWIG SUSAN E has filed SEC Form 4 disclosures for 1 company, including MEDP.

When was BURWIG SUSAN E's most recent SEC Form 4 filing?

BURWIG SUSAN E's most recent SEC Form 4 filing on Tracefour is dated Oct 28, 2026.

What is BURWIG SUSAN E's job title?

On the most recent SEC Form 4 filings tracked by Tracefour, BURWIG SUSAN E is listed as Exec. VP, Operations.

What is BURWIG SUSAN E's total buy and sell value in the current window?

Inside the rolling retention window, BURWIG SUSAN E bought $0 and sold $30.2M based on SEC Form 4 filings.

What was BURWIG SUSAN E's largest disclosed transaction?

The largest disclosed transaction in the current window is a sale of 20,000 MEDP shares on 2025-11-24, worth $12.2M, per SEC Form 4 filings.